Cargando…
New pathway ameliorating ulcerative colitis: focus on Roseburia intestinalis and the gut–brain axis
BACKGROUND: The community of gut microbes is a key factor controlling the intestinal barrier that communicates with the nervous system through the gut–brain axis. Based on our clinical data showing that populations of Roseburia intestinalis are dramatically decreased in the gut of patients with ulce...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053823/ https://www.ncbi.nlm.nih.gov/pubmed/33948112 http://dx.doi.org/10.1177/17562848211004469 |
_version_ | 1783680195220209664 |
---|---|
author | Xu, Fenghua Cheng, Yi Ruan, Guangcong Fan, Liqin Tian, Yuting Xiao, Zhifeng Chen, Dongfeng Wei, Yanling |
author_facet | Xu, Fenghua Cheng, Yi Ruan, Guangcong Fan, Liqin Tian, Yuting Xiao, Zhifeng Chen, Dongfeng Wei, Yanling |
author_sort | Xu, Fenghua |
collection | PubMed |
description | BACKGROUND: The community of gut microbes is a key factor controlling the intestinal barrier that communicates with the nervous system through the gut–brain axis. Based on our clinical data showing that populations of Roseburia intestinalis are dramatically decreased in the gut of patients with ulcerative colitis, we studied the efficacy of a strain belonging to this species in the context of colitis and stress using animal models. METHODS: Dextran sulfate sodium was used to induce colitis in rats, which then underwent an enema with R. intestinalis as a treatment. The disease activity index, fecal changes and body weight of rats were recorded to evaluate colitis, while histological and immunohistochemical analyses were carried out to examine colon function, and 16S rRNA sequencing was performed to evaluate the gut microbiota change. Behavioral assays and immunohistochemical staining of brain were performed to assess the effect of R. intestinalis on the gut–brain axis. RESULTS: Colitis-related symptoms in rats were significantly relieved after R. intestinalis enema, and the stool traits and colon length of rats were significantly recovered after treatment. The gut epithelial integrity and intestinal barrier were restored in treated rats, as evidenced by the higher expression of Zo-1 in colon tissues, accompanied by the restoration of gut microbiota. Meanwhile, depressive-like behaviors of rats were reduced after treatment, and laboratory experiments on neuronal cells also showed that IL-6, IL-7 and 5-HT were downregulated by R. intestinalis treatment in both serum and brain tissue, while Iba-1 expression was reduced in treated rats. CONCLUSIONS: The administration of R. intestinalis contributes to restoration of the gut microbiota, promoting colon repair and the recovery of gastrointestinal function. These alterations are accompanied by the relief of depressive-like behaviors through a process modulated by the neuronal network and the regulation of inflammation by the gut–brain axis. |
format | Online Article Text |
id | pubmed-8053823 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-80538232021-05-03 New pathway ameliorating ulcerative colitis: focus on Roseburia intestinalis and the gut–brain axis Xu, Fenghua Cheng, Yi Ruan, Guangcong Fan, Liqin Tian, Yuting Xiao, Zhifeng Chen, Dongfeng Wei, Yanling Therap Adv Gastroenterol Original Research BACKGROUND: The community of gut microbes is a key factor controlling the intestinal barrier that communicates with the nervous system through the gut–brain axis. Based on our clinical data showing that populations of Roseburia intestinalis are dramatically decreased in the gut of patients with ulcerative colitis, we studied the efficacy of a strain belonging to this species in the context of colitis and stress using animal models. METHODS: Dextran sulfate sodium was used to induce colitis in rats, which then underwent an enema with R. intestinalis as a treatment. The disease activity index, fecal changes and body weight of rats were recorded to evaluate colitis, while histological and immunohistochemical analyses were carried out to examine colon function, and 16S rRNA sequencing was performed to evaluate the gut microbiota change. Behavioral assays and immunohistochemical staining of brain were performed to assess the effect of R. intestinalis on the gut–brain axis. RESULTS: Colitis-related symptoms in rats were significantly relieved after R. intestinalis enema, and the stool traits and colon length of rats were significantly recovered after treatment. The gut epithelial integrity and intestinal barrier were restored in treated rats, as evidenced by the higher expression of Zo-1 in colon tissues, accompanied by the restoration of gut microbiota. Meanwhile, depressive-like behaviors of rats were reduced after treatment, and laboratory experiments on neuronal cells also showed that IL-6, IL-7 and 5-HT were downregulated by R. intestinalis treatment in both serum and brain tissue, while Iba-1 expression was reduced in treated rats. CONCLUSIONS: The administration of R. intestinalis contributes to restoration of the gut microbiota, promoting colon repair and the recovery of gastrointestinal function. These alterations are accompanied by the relief of depressive-like behaviors through a process modulated by the neuronal network and the regulation of inflammation by the gut–brain axis. SAGE Publications 2021-04-15 /pmc/articles/PMC8053823/ /pubmed/33948112 http://dx.doi.org/10.1177/17562848211004469 Text en © The Author(s), 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Xu, Fenghua Cheng, Yi Ruan, Guangcong Fan, Liqin Tian, Yuting Xiao, Zhifeng Chen, Dongfeng Wei, Yanling New pathway ameliorating ulcerative colitis: focus on Roseburia intestinalis and the gut–brain axis |
title | New pathway ameliorating ulcerative colitis: focus on Roseburia intestinalis and the gut–brain axis |
title_full | New pathway ameliorating ulcerative colitis: focus on Roseburia intestinalis and the gut–brain axis |
title_fullStr | New pathway ameliorating ulcerative colitis: focus on Roseburia intestinalis and the gut–brain axis |
title_full_unstemmed | New pathway ameliorating ulcerative colitis: focus on Roseburia intestinalis and the gut–brain axis |
title_short | New pathway ameliorating ulcerative colitis: focus on Roseburia intestinalis and the gut–brain axis |
title_sort | new pathway ameliorating ulcerative colitis: focus on roseburia intestinalis and the gut–brain axis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053823/ https://www.ncbi.nlm.nih.gov/pubmed/33948112 http://dx.doi.org/10.1177/17562848211004469 |
work_keys_str_mv | AT xufenghua newpathwayamelioratingulcerativecolitisfocusonroseburiaintestinalisandthegutbrainaxis AT chengyi newpathwayamelioratingulcerativecolitisfocusonroseburiaintestinalisandthegutbrainaxis AT ruanguangcong newpathwayamelioratingulcerativecolitisfocusonroseburiaintestinalisandthegutbrainaxis AT fanliqin newpathwayamelioratingulcerativecolitisfocusonroseburiaintestinalisandthegutbrainaxis AT tianyuting newpathwayamelioratingulcerativecolitisfocusonroseburiaintestinalisandthegutbrainaxis AT xiaozhifeng newpathwayamelioratingulcerativecolitisfocusonroseburiaintestinalisandthegutbrainaxis AT chendongfeng newpathwayamelioratingulcerativecolitisfocusonroseburiaintestinalisandthegutbrainaxis AT weiyanling newpathwayamelioratingulcerativecolitisfocusonroseburiaintestinalisandthegutbrainaxis |